In this episode of Spread Love in Organizations, Naji Gehchan sits down with Pedro Coelho, Founder and CEO of Biorce, to explore how artificial intelligence is transforming the future of clinical research. Pedro shares the deeply personal story that inspired his mission: the loss of his father to melanoma despite gaining access to an innovative clinical trial. That experience led him to question the inefficiencies of the clinical research ecosystem and ultimately fueled his determination to build technology that could help bring life-saving therapies to patients faster.
Pedro discusses how Biorce is reimagining clinical development through an AI-powered operating system designed to support every stage of the process—from asset strategy and protocol design to site selection, patient matching, and study execution. He explains how AI can identify avoidable protocol amendments, optimize trial design, and help organizations make smarter decisions with greater speed and precision. The conversation offers a fascinating look at how AI is evolving from a productivity tool into a strategic partner for drug development teams.
Beyond technology, Pedro reflects on leadership, culture, and the importance of keeping patients at the center of innovation. He shares why great leadership requires adaptability, humility, and a willingness to challenge conventional thinking. Together, Naji and Pedro explore a future where AI accelerates medical breakthroughs while human judgment, purpose, and compassion remain essential. It is an inspiring discussion about innovation, resilience, and the opportunity to transform healthcare for millions of patients around the world.
“If you don’t have a great culture, you will not succeed in the age of AI.”
MEET OUR GUEST Pedro Coelho Founder & CEO of Biorce.
Pedro Coelho is Founder & CEO of Biorce, an AI-native company transforming how clinical trials are designed, optimized, and executed. After years advising pharma and biotech companies as a strategy consultant in the life sciences sector, Pedro saw firsthand how inefficiencies in the clinical research process were slowing access to life-saving treatments. The consequences weren’t just operational; they were human. Drugs were too expensive. Timelines too long. And too many patients were left behind. In 2024, he founded Biorce to change that. Biorce, short for “Biology’s Force,” is building the world’s first true AI assistant for clinical trials. Pedro is passionate about the intersection of technology, data, and human impact, and believes AI has a central role to play in reshaping how treatments reach those who need them most.
EPISODE TRANSCRIPT: Pedro Coelho
Naji Gehchan: Welcome to SpreadLove in Organizations, the healthcare leadership podcast where we explore leadership with purpose. I’m Naji, your host, and I’m delighted to be joined today by Pedro Coelho, Founder and CEO of BIORCE, an AI-native company transforming how clinical trials are designed, optimized, and executed. After years advising pharmaceutical and biotech companies as a strategy consultant in the life sciences sector, Pedro saw firsthand how inefficiencies in clinical research were slowing access to life-saving treatments. The consequences weren’t just operational, they were human. Drugs were too expensive, timelines were too long, and too many patients were left…
